The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AMLSabine Käyser, Konstanze Döhner, Jürgen Krauter et al.|Blood|2010Cited by 485
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study GroupVerena I. Gaidzik, Konstanze Döhner, Lars Bullinger et al.|Journal of Clinical Oncology|2011Cited by 450
Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantationRichard F. Schlenk, Konstanze Döhner, Heinz A. Horst et al.|Blood|2014Cited by 400
Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study GroupJan Krönke, Konstanze Döhner, Richard F. Schlenk et al.|Journal of Clinical Oncology|2011Cited by 393
Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancerBrigitte Eibl, D Niederwieser, H Schwaighofer et al.|Blood|1996Cited by 269